retatrutide phase 2 trial type 2 diabetes weight loss 2024 Retatrutide: A Promising Option for Non-Diabetic in Clinical Trials More data on Retatrutide dropped – Taking Reta with type 1

New England Journal of Medicine 387 (3): 205 6

doi: 10.1093/ajcn/nqz285 12

DPP-4 Inhibitors : Concurrent use with DPP-4 inhibitors (e.g., sitagliptin) is usually not recommended, as both affect the GLP-1 pathway and do not provide additional benefit

The Effect of a Future-Self Avatar mHealth Intervention on Physical Activity and Food Purchases: The FutureMe Randomized Controlled Trial

Search (SciFinder database) 910463-68-2 Sequence search (Lens database) HXEGTFTSDVSSYLEGQAAKEFIAWLVRGRG Sequence search (NCBI Blast database) HXEGTFTSDVSSYLEGQAAKEFIAWLVRGRG Sequence search (SureChEMBL) HXEGTFTSDVSSYLEGQAAKEFIAWLVRGRG Mounjaro and Zepbound (tirzepatide) Keyword search ((+TIRZEPATID+ OR MOUNJARO+ OR ZEPBOUND+ OR LY3298176+ OR L__Y3298176 OR (LY 2W 3298176) OR (2023788__19__2) OR (2023788 2W 19 2W 2) OR TWINCRETIN OR GIP/GLP-1 RA OR GIP__GLP___1___RA OR (GIP 2W GLP 2W 1 2W RA) OR (DUAL__GIP__ GLP__1__AGONIST?) OR (DUAL 2W GIP 2W GLP 2W 1 2W AGONIST?) OR +YXEGTFTSDYSIXLDKIAQKAFVQWLIAGGPSSGAPPPS+) Broad drug category Keyword search (((GLUCAGON__LIKE__PEPTIDE__1) OR (GLUCAGON 3W LIKE 3W PEPTIDE 3W 1) OR (GLP__1) OR (GLP 3W 1) OR GLP__1RA OR (GLP 2W 1RA) OR GLP__1R+ OR GLP1 OR (GLUCOSE__DEPENDENT__INSULINOTROPIC__POLYPEPTIDE+) OR (GLUCOSE 2W DEPENDENT 2W INSULINOTROPIC 2W POLYPEPTIDE+) OR (GASTRIC__INHIBITORY__POLYPEPTIDE+) OR (GASTRIC 2W INHIBITORY 2W POLYPEPTIDE+) OR GIP OR GIPR OR GIP_R OR GIP_R

We need to stop thinking of HFpEF as purely a cardiac disease, added Prasad